The relationship between executive function impairment and serotonergic sensitivity in obsessive-compulsive disorder

Eric Hollander, Cheryl M. Wong

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

While studies of obsessive-compulsive disorder (OCD) have demonstrated both neuropsychological and serotonergic (5-HT) dysfunction, none have integrated these two spheres. We report concomitant abnormalities in both areas that may impact on the pathophysiology and treatment of OCD. We utilized Trail-making B-A, a neuropsychological test of cognitive set-switching, to highlight executive function abnormalities in OCD patients (N = 50) and normal controls (N = 31). OCD patients were found to be significantly impaired on Trails B-A. Prolactin response to double-blind, single-dose meta-chlorophenyl piperazine (m-CPP) and placebo served as a measure of 5-HT sensitivity. OCD patients (N = 42) had a blunted prolactin response to m-CPP, in contrast to normal controls (N = 15; F = 2.462; df = 3.62; p = 0.06). Of interest, the peak δ-prolactin response to m-CPP significantly negatively correlated with frontal lobe set-switching impairment in OCD patients (r = 0.37, n = 26, p = 0.03) but not in normal controls. This suggested that OCD patients with greater frontal lobe impairment had concomitantly more substantial serotonergic dysfunction.

Original languageEnglish (US)
Pages (from-to)230-233
Number of pages4
JournalNeuropsychiatry, Neuropsychology and Behavioral Neurology
Volume9
Issue number4
StatePublished - Oct 1996
Externally publishedYes

Fingerprint

Obsessive-Compulsive Disorder
Executive Function
Prolactin
Frontal Lobe
Serotonin
Neuropsychological Tests
Placebos
piperazine

Keywords

  • Neuropsychology
  • Obsessive-compulsive disorder
  • Serotonin

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology
  • Psychiatry and Mental health
  • Psychology(all)

Cite this

@article{9d66f1795a9748daa83e4b8700820754,
title = "The relationship between executive function impairment and serotonergic sensitivity in obsessive-compulsive disorder",
abstract = "While studies of obsessive-compulsive disorder (OCD) have demonstrated both neuropsychological and serotonergic (5-HT) dysfunction, none have integrated these two spheres. We report concomitant abnormalities in both areas that may impact on the pathophysiology and treatment of OCD. We utilized Trail-making B-A, a neuropsychological test of cognitive set-switching, to highlight executive function abnormalities in OCD patients (N = 50) and normal controls (N = 31). OCD patients were found to be significantly impaired on Trails B-A. Prolactin response to double-blind, single-dose meta-chlorophenyl piperazine (m-CPP) and placebo served as a measure of 5-HT sensitivity. OCD patients (N = 42) had a blunted prolactin response to m-CPP, in contrast to normal controls (N = 15; F = 2.462; df = 3.62; p = 0.06). Of interest, the peak δ-prolactin response to m-CPP significantly negatively correlated with frontal lobe set-switching impairment in OCD patients (r = 0.37, n = 26, p = 0.03) but not in normal controls. This suggested that OCD patients with greater frontal lobe impairment had concomitantly more substantial serotonergic dysfunction.",
keywords = "Neuropsychology, Obsessive-compulsive disorder, Serotonin",
author = "Eric Hollander and Wong, {Cheryl M.}",
year = "1996",
month = "10",
language = "English (US)",
volume = "9",
pages = "230--233",
journal = "Cognitive and Behavioral Neurology",
issn = "1543-3633",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - The relationship between executive function impairment and serotonergic sensitivity in obsessive-compulsive disorder

AU - Hollander, Eric

AU - Wong, Cheryl M.

PY - 1996/10

Y1 - 1996/10

N2 - While studies of obsessive-compulsive disorder (OCD) have demonstrated both neuropsychological and serotonergic (5-HT) dysfunction, none have integrated these two spheres. We report concomitant abnormalities in both areas that may impact on the pathophysiology and treatment of OCD. We utilized Trail-making B-A, a neuropsychological test of cognitive set-switching, to highlight executive function abnormalities in OCD patients (N = 50) and normal controls (N = 31). OCD patients were found to be significantly impaired on Trails B-A. Prolactin response to double-blind, single-dose meta-chlorophenyl piperazine (m-CPP) and placebo served as a measure of 5-HT sensitivity. OCD patients (N = 42) had a blunted prolactin response to m-CPP, in contrast to normal controls (N = 15; F = 2.462; df = 3.62; p = 0.06). Of interest, the peak δ-prolactin response to m-CPP significantly negatively correlated with frontal lobe set-switching impairment in OCD patients (r = 0.37, n = 26, p = 0.03) but not in normal controls. This suggested that OCD patients with greater frontal lobe impairment had concomitantly more substantial serotonergic dysfunction.

AB - While studies of obsessive-compulsive disorder (OCD) have demonstrated both neuropsychological and serotonergic (5-HT) dysfunction, none have integrated these two spheres. We report concomitant abnormalities in both areas that may impact on the pathophysiology and treatment of OCD. We utilized Trail-making B-A, a neuropsychological test of cognitive set-switching, to highlight executive function abnormalities in OCD patients (N = 50) and normal controls (N = 31). OCD patients were found to be significantly impaired on Trails B-A. Prolactin response to double-blind, single-dose meta-chlorophenyl piperazine (m-CPP) and placebo served as a measure of 5-HT sensitivity. OCD patients (N = 42) had a blunted prolactin response to m-CPP, in contrast to normal controls (N = 15; F = 2.462; df = 3.62; p = 0.06). Of interest, the peak δ-prolactin response to m-CPP significantly negatively correlated with frontal lobe set-switching impairment in OCD patients (r = 0.37, n = 26, p = 0.03) but not in normal controls. This suggested that OCD patients with greater frontal lobe impairment had concomitantly more substantial serotonergic dysfunction.

KW - Neuropsychology

KW - Obsessive-compulsive disorder

KW - Serotonin

UR - http://www.scopus.com/inward/record.url?scp=0029820855&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029820855&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0029820855

VL - 9

SP - 230

EP - 233

JO - Cognitive and Behavioral Neurology

JF - Cognitive and Behavioral Neurology

SN - 1543-3633

IS - 4

ER -